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ABSTRACT
Introduction Early identification of frailty by clinical 
instruments or accumulation of deficit indexes can 
contribute to improve healthcare for older adults, 
including the prevention of negative outcomes in acute 
care. However, conflicting evidence exists on how to 
best capture frailty in this setting. Simultaneously, the 
increasing utilisation of electronic health records (EHRs) 
opens up new possibilities for research and patient care, 
including frailty.
Methods and analysis The Swiss Frailty Network and 
Repository (SFNR) primarily aims to develop an electronic 
Frailty Index (eFI) from routinely available EHR data in 
order to investigate its predictive value against length of 
stay and in- hospital mortality as two important clinical 
outcomes in a study sample of 1000–1500 hospital 
patients aged 65 years and older. In addition, we will 
examine the correlation between the eFI and a test- based 
clinical Frailty Instrument to compare both concepts in 
Swiss older adults in acute care settings. As a Swiss 
Personalized Health Network (SPHN) driver project, our 
study will report on the characteristics and usability of 
the first nationwide eFI in Switzerland connecting all five 
Swiss University Hospitals’ Geriatric Departments with a 
representative sample of patients aged 65 years and older 
admitted to acute care.
Ethics and dissemination The study protocol was 
approved by the competent ethics committee of the 
Canton of Zurich (BASEC- ID 2019-00445). All acquired 
data will be handled according to SPHN’s ethical 
framework for responsible data processing in personalised 
health research. Analyses will be performed within the 
secure BioMedIT environment, a national infrastructure to 
enable secure biomedical data processing, an integral part 
of SPHN.
Trial registration number NCT04516642.
INTRODUCTION
With the ongoing demographical transfor-
mation, ageing societies convey an important 
challenge to present healthcare systems due 
to the growing number of older adults living 
with accumulating deficits, multimorbidity 
and frailty.1 At the same time, healthcare 
informatics with its expanding amount of 
routinely collected, electronic patient data 
comprises a huge potential for the exploita-
tion of data for research purposes and future 
developments in personalised medicine. In 
order to avoid age discrimination, this should 
also include the utilisation of electronic 
patient data in the interest of older adults.
Over the last two decades, frailty was charac-
terised as an age- associated disproportionate 
decline in physiological reserves leading to 
increased vulnerability to external stressors,2 
and shown to be an important predictor of 
negative health outcomes in older adults.3 
Nonetheless, frailty is still underdiagnosed 
in acute care although frail older adults have 
more frequent and longer hospital stays, are 
Strengths and limitations of this study
 ► This large multicentre study, recruiting 1000–1500 
individuals will establish a new harmonised elec-
tronic Frailty Index (eFI) from routinely collected 
electronic patient data at all five Swiss academic 
geriatric centres.
 ► The new eFI has the potential to predict two very 
important adverse outcomes in acute care, length of 
stay and in- hospital mortality.
 ► Furthermore, these new data will be used to inves-
tigate the correlation between the eFI and a stan-
dardised clinical Frailty Instrument.
 ► Our study is not intended to establish long- term out-
comes in participants identified as frail versus their 
robust counterparts.
 ► No report on potential interventions for participants 
identified as frail or at- risk of becoming frail is in-
cluded at this stage of the project, however we aim 
to lay groundwork for a future implementation of 
frailty screening in clinical care.
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re- hospitalised more often and eventually die earlier than 
their non- frail counterparts.3 4
The British Geriatrics Society issued a recommenda-
tion for routine frailty screening in geriatric outpatients 
in order to timely assess the risk of frailty on the health 
of older adults.5 Moreover, frailty is becoming more and 
more recognised as a useful concept for risk stratification 
in various medical specialties, from oncology to heart 
surgery.6 However, as the field is evolving, there has been 
no agreement either on the ideal conceptualisation of 
frailty or on a single best screening instrument over the 
past decades.7–10 This happened to be a major roadblock 
for the broader implementation of the frailty concept into 
patient care.11 At the same time, assessing frailty systemat-
ically in clinical care might open up a window of opportu-
nity for both improving patient care for older adults and 
accelerating research efforts for a better understanding 
of the underlying pathophysiology of frailty as a state or 
condition (ie, by a Frailty Index (FI) approach) and as a 
syndrome (ie, the frailty phenotype).10
Today, among the highly cited frailty conceptualisa-
tions, the frailty phenotype by Fried et al12 and the deficit 
accumulation concept (ie, FI) by Mitnitski et al13 stand 
out as the two most extensively investigated approaches 
of frailty.14 As this two approaches measure different 
concepts of frailty (ie, a clinical syndrome vs a multi- 
system decline based index), their comparability may 
be limited. In addition, it should be taken into account 
that the phenotype usually requires clinical measure-
ments, whereas a FI can be generated from available 
patient data collected during routine clinical practice. 
Therefore, deriving a FI from electronic health records 
(EHRs) data that are routinely collected, has the poten-
tial to expedite the routine identification of frail patients 
in acute hospital care in various medical specialties, as 
no additional resources are needed.15 This approach 
has been recently demonstrated by Cesari et al investi-
gating a FI in an Italian cohort of hospitalised patients.16 
With regard to the investigation of significant clinical 
endpoints including in- hospital mortality and length of 
stay (LOS) by an electronic Frailty Index (eFI), which has 
not been undertaken in hospitalised older adults in Swit-
zerland so far, a comparative view on both frailty concepts 
contains the opportunity to provide important additional 
information.
The Swiss Frailty Network and Repository (SFNR) aims 
to establish a nationwide harmonised eFI consisting of 55 
variables from routinely collected EHR data in patients 
aged 65 years and older at all five Swiss University Hospi-
tals in order to investigate its predictive abilities in regard 
to LOS and in- hospital mortality. A secondary validation 
aim investigates the correlation of the eFI as a screening 
tool against the detection of frailty by a harmonised clin-
ical Frailty Instrument (cFI) based on the Fried pheno-
type concept, in a subset of patients aged 65 years and 
older from acute geriatric care at all five Swiss University 
Hospitals’ geriatric centres. In order to take into account 
the importance of cognitive impairment with regard to 
frailty, we have added a short cognitive test as an addi-
tional component to the cFI.17 18 We will investigate the 
predictive abilities of both, the eFI and the cFI regarding 
two important outcomes in acute hospital care, LOS and 
in- hospital mortality. The development of a frailty data 
repository will in addition serve as a basic personalised 
health research infrastructure for future studies in older 
adults across all partner institutions.
The utilisation of routinely collected, electronic patient 
data is a major focus area in healthcare, and of growing 
interest in many acute care settings, including geriatric 
medicine. Frailty is highly prevalent in older patients and 
appears as a major driver of multiple negative outcomes 
in this population. Establishing a harmonised eFI from 
routinely collected EHR data is therefore a timely effort 
that will likely contribute to the improvement of care for 
older adult patients by early identifying those at increased 
risk for adverse outcomes.
The main deliverable of the SFNR will be to establish 
a nationwide eFI derived from routinely collected elec-
tronic patient data for older adults in Switzerland curated 
within the Swiss Personalized Health Network (SPHN) 
BioMedIT ecosystem. We aim to demonstrate the eFI’s 
predictive ability for LOS and in- hospital mortality and 
investigate the comparative performance of the eFI in the 
detection of frailty against our cFI in a subset of patients 
admitted to acute geriatric care.
Our proposition of a systematic clinical evaluation 
of frailty using the cFI as a clinical research reference 
standard in all enrolled patients admitted to acute geri-
atric care at all five Swiss Academic geriatric centres is a 
secondary outcome of our collaboration that may lead 
to a more unified approach to the measurement of the 
frailty phenotype on the national level. Therefore, estab-
lishing the SFNR will likely advance both, the field of geri-
atric medicine and research in Switzerland. Incorporating 
frailty as a criterion in acute care will allow a systematic 
and personalised pre- therapeutic stratification of patients 
according to each patient’s profile. This individualised 
approach will enhance the definition of person- based 
potential harms and benefits of interventions in various 
medical disciplines, ranging from emergency medicine 
and orthogeriatric units to cardiovascular surgery and 
comprehensive cancer care. We expect first results to be 
ready for scientific publication by mid 2022.
METHODS AND ANALYSIS
The SFRN is a joint effort by all five Swiss Academic Geri-
atric Departments (Universities of Basel, Bern, Geneva, 
Lausanne and Zurich and adjacent University Hospitals) 
that is funded by the SPHN (grant no. 2017DRI02), an 
initiative of the Swiss Federal Government, namely the 
State Secretariat for Education, Research and Innovation 
and the Federal Office of Public Health.19
The SFNR has five primary aims:
1. Reaching a consensus on a nationwide research 
reference standard to assess frailty clinically in geriatric 
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patients at all five partner sites (definition of cFI, goal 1), 
see table 1.
2. Reaching a consensus on the candidate variables 
aggregating to a harmonised eFI from regularly collected 
electronic patient data extracted from the local clinical 
information systems (CISs) at all five sites (goal 2), table 2.
3. Setting up of a frailty data hub for the collection, 
organisation and maintenance of coded data from all five 
centres including both, the cFI from patients in acute 
care seen by the geriatric teams at each site (related to 
goal 1) and the harmonised eFI (related to goal 2) from 
all patients aged 65 years and older at the partnering 
Swiss University Hospitals.
4. Investigating the correlation of the eFI as a screening 
tool against the cFI as a clinical criterion standard within 
the pooled data set from all five geriatric centres (associ-
ation study).
5. Investigating whether the prognostic abilities differ 
between the cFI and the eFI with regard to the prediction 
of LOS and in- hospital mortality in acute geriatric care 
(correlation study).
Sample size calculation
For our study, the estimated total sample size of 1000–1500 
patients within a 12- month planned period was based on 
the two primary endpoints, hospital LOS and in- hospital 
mortality. In a prior study, Hope et al found a median 
(IQR) LOS in the hospital for non- frail and frail individ-
uals to be 13 (IQR 8–23) days and 17 (IQR 10–30) days, 
respectively.20 Assuming symmetry, this translates to a 
mean (SD) of 13 (SD=(23−8)/1.35=11.1) days for non- 
frail individuals and 17 (14.8) days for frail individuals.21 
Another study investigating older adult medical inpa-
tients found a range in LOS between 4.2 and 7.8 along a 
FI score based on a comprehensive geriatric assessment.22 
In addition, a systematic review and meta- analysis of nine 
observational studies investigating outcomes in general 
surgery reported a mean LOS of 9.6 days (95% CI: 6.2 
to 12.9) in frail and 6.4 days (4.9 to 7.9) in non- frail 
patients.23 Conservatively assuming 20% of older adults 
in acute care are frail (expected range from literature 
20%–50%)24 and assuming a difference in hospital LOS 
of 4 days, a total of 418 persons (92 frail, 326 non- frail) 
would be needed to achieve 80% power at the 0.05 alpha 
level. Using a more conservative estimate of detecting a 
difference in hospital LOS of 2 days, 1655 (364 frail, 1291 
non- frail) individuals would be needed to achieve 80% 
power at the 0.05 alpha level. Vermeiren et al conducted 
a meta- analysis of 24 prospective studies comprising over 
150 000 individuals and found frailty to increase the like-
lihood of mortality more than twofold (OR 2.34 (1.77 
to 3.09)).3 We assume 20% of individuals are frail, and 
leave room for a greater degree of uncertainty (wider CI, 
CI 1.42 to 3.91) since this is a single study as opposed 
to a large meta- analysis comprising many individuals. For 
a mortality rate of 5% in non- frail individuals, a total of 
1077 persons (237 frail, 840 non- frail) would be required 
to detect an OR=2.34 at the 0.05 confidence level.
In summary, we consider a sample size of approxi-
mately 200–300 patients enrolled at each of the five part-
nering sites over the planned 12- month period sufficient 
to answer our research questions. However, the number 
of recruited participants at each site might not be equally 
distributed and differ largely due to the local environ-
ments and in- patient capacities. Of note, the primary 
analysis will be performed on the total sample of 1000–
1500 patients.
Table 1 Components of the SFNR clinical Frailty Instrument
Domain (item) Operationalisation (test- based) Cut- point (threshold)
Shrinking (weight loss) Unintentional weight loss or loss of appetite; report of lose 
clothing, weight loss documented in patient chart
Any reported weight loss or loss of 
appetite or lose clothing or
>5% last 6 months (from EHR)
Fatigue Self- reported exhaustion measured by Geriatric 
Depression Scale (GDS) 4 item
≥2 Points on GDS-431 32
Slowness Slow gait speed on standardised 4 m measurement from a 
standing start (best of two consecutive measurements)
Gait speed below 0.8 m/s
Weakness Low hand grip strength measured by the Martin 
Vigorimeter (in Kilopascal), best of three consecutive trials 
at the dominant hand at time of assessment
Below the median of lowest 20% (by 
gender and age <75 and ≥75 years) 
compared with a sample of generally 
healthy Swiss older adults (from the DO- 
HEALTH study33 3435 
Low activity level Reported frequency of activities with moderate energy 
expenditure (question BR016_ModSprtsAct from SHARE 
questionnaire36
Answer of ‘less than once a week’
Cognition Three item recall and clock drawing test (CDT) Any error in recall or CDT indicates 
cognitive disturbance
EHR, electronic health record; SFNR, Swiss Frailty Network and Repository.
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Table 2 Variables and coding of the SFNR electronic Frailty Index (eFI)











3. Problems with falling/staying asleep
4. Problems with sleep–awake cycle
5. Urinary incontinence
6. Help getting on/off bed
7. Help going to the toilet
8. Help walking
9. History of falls
10. Inability to walk stairs
11. Irregular gait pattern
12. Patient using walking equipment/aid
13. Problems getting dressed
14. Problems with bathing
15. Clouding or delirium   
  Yes=1, no=0







19. History of osteoporosis
20. Cardiac arrhythmias
21. Coronary heart disease
22. Pressure sores (decubital ulcers)
23. Diabetes mellitus
24. History of seizures
25. History of stroke
26. Memory impairment
27. Chronic obstructive lung disease
28. Use of anticoagulation medication
29. Use of antiplatelet medication
30. Polypharmacy (>5 drugs)
31. Use of sedative, hypnotic and/or 
neuroleptic drugs












39. C- reactive protein
40. Lymphocyte total count




45. Blood glucose   
<35%=1,≥35%=0
Serum concentration above or below 
reference range=1, within=0
<3.9 or>15 mmol/L=1, other=0
>7 or<3.5 mmol/L=1, other=0
46. Cholesterol
Vital signs EHRs 47. Body temperature
48. Diastolic blood pressure
49. Heart rate (pulse)
50. Systolic blood pressure
51. Oxygen saturation (SpO2)
52. Patient requires supplemental oxygen
<36,3°C=1,≥36,3°C=0
>90mmHg=1,≤90 mmHg=0




Other EHRs 53. Age
54. Body mass index
55. Patient reports being in pain
>80=1,≤80=0
<18.5 or≥30=1;>25 and<30=0.5, other=0
yes=1, no=0
SFNR, Swiss Frailty Network and Repository.
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Data collection
The data collection for the components of the cFI will 
take place within the first 4 days on admission to acute 
geriatric care at all partner sites by certified examiners 
following a standardised protocol. For calculating the 
eFI, only variables available from within 4 days on admis-
sion will be retrieved from the EHR and included to the 
dataset.
Statistical analysis
In regard to the eFI’s variables, each will be scored as either 
‘1’, that is, presence of the deficit or ‘0’, that is, absence 
of the deficit, except for body mass index (<18.5 or ≥30 = 
1, >25 and <30 = 0.5, other=0), see table 2 for full list of 
variables. We will use validated cut- points regarding the 
classification of the degree of robustness or frailty from 
prior literature.25 26 We will additionally test, whether 
eFI scores differ between the classification of frail/pre- 
frail and robust by the cFI in our subsample from acute 
geriatric care. To evaluate the ability of the eFI screening 
tool to correctly classify each patient as frail, pre- frail or 
non- frail in regard to the phenotypic approach, we will 
calculate the sensitivity, specificity, as well as positive and 
negative predictive values of the eFI (pre- defined cut- offs 
and tertiles) against the cFI.27 Each potential threshold 
will be applied to the continuous total sum scores of the 
eFI to classify frail vs non- frail participants. The resulting 
true positive rate (sensitivity) and false positive rate (1–
specificity) will be determined using the cFI as the refer-
ence. A receiver operating characteristic (ROC) curve 
will be constructed for all possible thresholds of the eFI. 
Discriminative ability will be estimated based on the area 
under the ROC curve and associated C statistics.
Hospital LOS in frail and non- frail individuals (clas-
sified by eFI and cFI) will be summarised using mean, 
median, SD, IQR, minimum and maximum. Differences 
in hospital LOS between frail and non- frail individuals 
will be tested using a two- sided independent t test, or 
Mann- Whitney U test if the data is skewed, at the 0.05 
level. In- hospital mortality rates will be calculated for the 
overall sample as well as for frail and non- frail subgroups. 
Logistic regression will be used to quantify the association 
of frail (vs non- frail) on in- hospital mortality.
Progress to date
In the first year of the project, consensus was reached 
among the project partners regarding the composition 
and scoring of the cFI. At the same time, the 55 variables 
summarised in the eFI were defined and harmonised. In 
the second year, the local requirements for the provision 
of the data to be collected were analysed and the required 
IT infrastructure for secure data processing and delivery 
was set up. At the same time, the project- related data 
infrastructure within the BioMedIT network was defined 
and made available by SPHN. Enrolment of first partici-
pants into the study began in June 2020.
Patient and public involvement
Patients and the general public were not involved in the 
design, recruitment and implementation of our study. 
Participants will be informed regarding the detailed 
results of our study only on request. However, the results 
will be disseminated to the public according to the 
SPHN’s dissemination policy and by published articles.
ETHICS AND DISSEMINATION
For the association study, with regard to the eFI, we will 
use data from consecutive patients aged 65 years and 
older admitted to acute care on various departments of 
the partnering university hospitals from a determined 
starting date and with available written informed consent 
for further use of routine clinical data. For the correla-
tion study, we will use data from all patients aged 65 years 
and older recruited from acute geriatric care units who 
agreed to participate in the study by informed consent.
All ethics committees of the involved partner sites, 
chaired by the ethics committee of the Canton of 
Zurich have approved our study (swissethics BASEC- ID 
2019-00445).
SPHN IT ecosystem
Our project’s hosting initiative, the SPHN, is currently 
developing a nationwide healthcare data ecosystem in 
Switzerland to work towards interoperability of data from 
local information systems, for example, clinical data 
management systems in enabling an effective exchange 
of patient data (eg, disease phenotypes) for research with 
the ultimate goal of advancing personalised medicine.28 29 
Our project will support and build on this effort as a driver 
project. In a first step, the agreed set of eFI variables was 
submitted to the SPHN Clinical Semantic Interoperability 
Working Group, which has integrated the variables in a 
Swiss wide core dataset and is defining for each variable 
in which format they shall be shared and which additional 
(meta-) data are needed for optimal interoperability. 
The data of the test- based cFI will be collected in a stan-
dardised and centralised electronic Case Report Form 
in REDCap (Vanderbilt University, Nashville, Tennessee, 
USA) or in the CIS (EHR).
Next, our collected data (eFI and cFI) will be locally 
pre- processed by the clinical data warehouse teams. In 
particular, patient IDs will be mapped and de- identi-
fied before sharing to respect data privacy regulations.19 
Additionally, a standardised format for data transfer 
defined by a Data Coordination Center (DCC) will be 
used in order to allow interoperability. We will used the 
novel Swiss BioMedIT- Node secure data infrastructure 
currently under development by the Swiss Institute of 
Bioinformatics and managed by the Personalized Health 
Informatics Group and coordinated by the DCC as part of 
SPHN.30 The de- identified data will be encrypted with a 
secure, standard mechanism (GPG, GNU Privacy Guard) 
and sent via secure transfer to BioMedIT.
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On BioMedIT, the analysis of the data will take place 
using state of the art software and tools thereby ensuring 
highest security levels for access to data, processing 
and sharing. FAIR data principles (findability, accessi-
bility, interoperability, reusability) will be respected and 
ensured throughout the project in accordance with 
SPHN strategy.
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